Showing results (11-20 of 118) with videos related to
Sort By:
Pageof 12
Journal of Environmental Radioactivity|March 16, 2019
Six-year trends in exchangeable radiocesium in Fukushima forest soilsTakuya Manaka, Naohiro Imamura, Shinji Kaneko, et al.Applied Spectroscopy|December 12, 2007
Carbon analysis for inspecting carbonation of concrete using a TEA CO2 laser-induced plasmaKiichiro Kagawa, Nasrullah Idris, Munehide Wada, et al.Plos One|December 8, 2023
Variability in radiocesium activity concentration in growing hardwood shoots in Fukushima, JapanHiroki Itô, Satoru Miura, Masabumi Komatsu, et al.Peerj|October 30, 2019
Efficient sampling of shiitake-inoculated oak logs to determine the log-to-mushroom transfer factor of stable cesiumMartin O'Brien, Masakazu Hiraide, Yoshimi Ohmae, et al.Journal of Environmental Radioactivity|September 13, 2020
Seasonal changes in radiocesium and potassium concentrations in current-year shoots of saplings of three tree species in Fukushima, JapanTanaka Kenzo, Satoshi Saito, Satoru Miura, et al.Cancer Science|March 3, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancerYasushi Goto, Takehito Shukuya, Ai Murata, et al.Journal of Environmental Radioactivity|January 31, 2024
Effect of litter removal five years after the Fukushima accident on 137Cs uptake by Japanese cedarYoshimi Ohmae, Wataru Sakashita, Tadashi Sakata, et al.Applied Spectroscopy|February 4, 2006
Measurement of concrete strength using the emission intensity ratio between Ca(II) 396.8 nm and Ca(I) 422.6 nm in a Nd:YAG laser-induced plasmaKenichiro Tsuyuki, Satoru Miura, Nasrullah Idris, et al.Journal of Environmental Radioactivity|July 8, 2026
Empirical relationship for predicting radiocesium inventory and concentration in forest soils from ambient dose equivalent rates under quasi-equilibrium conditionsWataru Sakashita, Yoshiki Shinomiya, Tadashi Sakata, et al.Cancers|October 14, 2022
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?Satoshi Ikeda, Tateaki Naito, Satoru Miura, et al.Pageof 12